213 related articles for article (PubMed ID: 31404562)
1. Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
Bharucha T; Gangadharan B; Kumar A; de Lamballerie X; Newton PN; Winterberg M; Dubot-Pérès A; Zitzmann N
J Infect; 2019 Nov; 79(5):407-418. PubMed ID: 31404562
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
4. Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples.
Lévêque N; Legoff J; Mengelle C; Mercier-Delarue S; N'guyen Y; Renois F; Tissier F; Simon F; Izopet J; Andréoletti L
J Clin Microbiol; 2014 Jan; 52(1):212-7. PubMed ID: 24197874
[TBL] [Abstract][Full Text] [Related]
5. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases.
Aibara N; Ichinose K; Baba M; Nakajima H; Satoh K; Atarashi R; Kishikawa N; Nishida N; Kawakami A; Kuroda N; Ohyama K
Clin Chim Acta; 2018 Sep; 484():26-31. PubMed ID: 29775619
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
Shi M; Movius J; Dator R; Aro P; Zhao Y; Pan C; Lin X; Bammler TK; Stewart T; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Zhang J
Mol Cell Proteomics; 2015 Mar; 14(3):544-55. PubMed ID: 25556233
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of viral cerebrospinal fluid PCR testing for diagnosis of central nervous system disorders: a retrospective 11-year experience.
Kleines M; Scheithauer S; Schiefer J; Häusler M
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):207-15. PubMed ID: 25178670
[TBL] [Abstract][Full Text] [Related]
9. A metagenomics-based diagnostic approach for central nervous system infections in hospital acute care setting.
Hasan MR; Sundararaju S; Tang P; Tsui KM; Lopez AP; Janahi M; Tan R; Tilley P
Sci Rep; 2020 Jul; 10(1):11194. PubMed ID: 32641704
[TBL] [Abstract][Full Text] [Related]
10. Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders.
Fortuna D; Hooper DC; Roberts AL; Harshyne LA; Nagurney M; Curtis MT
PLoS One; 2018; 13(10):e0205501. PubMed ID: 30379898
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections.
Onyango CO; Loparev V; Lidechi S; Bhullar V; Schmid DS; Radford K; Lo MK; Rota P; Johnson BW; Munoz J; Oneko M; Burton D; Black CM; Neatherlin J; Montgomery JM; Fields B
J Clin Microbiol; 2017 Jul; 55(7):2035-2044. PubMed ID: 28404679
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy.
Tan N; Hu S; Hu Z; Wu Z; Wang B
Mol Med Rep; 2020 Aug; 22(2):1257-1268. PubMed ID: 32468033
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China.
Yang R; Zhang H; Xiong Y; Gui X; Zhang Y; Deng L; Gao S; Luo M; Hou W; Guo D
AIDS Res Ther; 2017; 14():24. PubMed ID: 28469695
[TBL] [Abstract][Full Text] [Related]
15. Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry.
Noben JP; Dumont D; Kwasnikowska N; Verhaert P; Somers V; Hupperts R; Stinissen P; Robben J
J Proteome Res; 2006 Jul; 5(7):1647-57. PubMed ID: 16823972
[TBL] [Abstract][Full Text] [Related]
16. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
[TBL] [Abstract][Full Text] [Related]
17. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
18. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
19. Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections.
Zatta M; Di Bella S; Bottazzi B; Rossi F; D'Agaro P; Segat L; Fabbiani M; Mantovani A; Luzzati R
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):665-670. PubMed ID: 31813079
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.
Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maître E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson PJ; Lampa J
Arthritis Res Ther; 2019 Feb; 21(1):60. PubMed ID: 30770760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
